Skip to main content
Article
Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?
Journal of the American Academy of Child & Adolescent Psychiatry
  • Jose de Leon, University of Kentucky
Document Type
Article
Publication Date
7-1-2015
Notes/Citation Information

Published in Journal of the American Academy of Child & Adolescent Psychiatry, v. 54, no. 7, p. 532–534.

© 2015 American Academy of Child and Adolescent Psychiatry

This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

Digital Object Identifier (DOI)
http://dx.doi.org/10.1016/j.jaac.2015.04.003
Citation Information
Jose de Leon. "Translating Pharmacogenetics to Clinical Practice: Do Cytochrome P450 2D6 Ultrarapid Metabolizers Need Higher Atomoxetine Doses?" Journal of the American Academy of Child & Adolescent Psychiatry Vol. 54 Iss. 7 (2015) p. 532 - 534
Available at: http://works.bepress.com/jdeleon/88/